Bjork Elisabeth
Insider CIK 1810406 · RCKT Director · PHVS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHVS Pharvaris N.V. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 17,500 | — | $0 | 0 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 35,000 | — | $0 | 0 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-09-17 | 2026-09-21 | 52,500 | $37.89 | $1.99M | 15,167 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 17,500 | $18.14 | $317.4K | 67,667 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 35,000 | $14.39 | $503.6K | 50,167 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 17,500 | — | $0 | 0 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 35,000 | — | $0 | 0 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-09-17 | 2026-09-21 | 52,500 | $37.89 | $1.99M | 15,167 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 17,500 | $18.14 | $317.4K | 67,667 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-09-17 | 2026-09-21 | 35,000 | $14.39 | $503.6K | 50,167 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise deriv | 2026-05-20 | 2026-05-22 | 10,000 | — | $0 | 11,000 | SEC↗ |
| PHVS Pharvaris N.V. | M Exercise | 2026-05-20 | 2026-05-22 | 10,000 | $8.05 | $80.5K | 25,167 | SEC↗ |
| PHVS Pharvaris N.V. | S Sale | 2026-05-20 | 2026-05-22 | 10,000 | $29.32 | $293.2K | 15,167 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | P Buy | 2026-01-02 | 2026-01-06 | 10,000 | $3.44 | $34.4K | 50,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | P Buy | 2025-08-27 | 2025-08-27 | 10,000 | $3.41 | $34.1K | 40,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award | 2025-06-18 | 2025-07-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-09-26 | 2024-10-29 | 607 | — | $0 | 607 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-06-13 | 2024-06-20 | 3,325 | $15.04 | $50.0K | 3,325 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2024-06-13 | 2024-06-20 | 23,944 | — | $0 | 23,944 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-06-22 | 2023-06-26 | 25,850 | — | $0 | 25,850 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2023-06-22 | 2023-06-26 | 3,590 | $13.93 | $50.0K | 3,590 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-06-13 | 2022-06-15 | 47,745 | — | $0 | 47,745 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2022-06-13 | 2022-06-15 | 7,345 | $6.80 | $49.9K | 7,345 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-06-14 | 2021-06-16 | 1,699 | $29.42 | $50.0K | 1,699 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2021-06-14 | 2021-06-16 | 12,236 | — | $0 | 12,236 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2020-06-16 | 2020-06-18 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCKT ROCKET PHARMACEUTICALS, IN | A Award deriv | 2020-04-20 | 2020-04-22 | 40,000 | — | $0 | 40,000 | SEC↗ |